Sherwin-Williams beats Q2 earnings, raises FY26 guidance
Sherwin-Williams Co surged 7.8% after beating Q2 EPS and sales estimates, raising FY26 guidance. Other gainers included Kiniksa Pharmaceuticals, OPKO Health, and Itron, which posted strong earnings or strategic updates. The Dow Jones gained around 300 points in mixed trading.
*this image is generated using AI for illustrative purposes only.
Sherwin-Williams Co shares rose 7.8% to $352.89 on Tuesday after the company reported better-than-expected second-quarter financial results and raised its FY26 guidance. The paint and coatings manufacturer delivered quarterly earnings of $3.70 per share, beating the analyst consensus estimate of $3.52 per share. Quarterly sales reached $6.789 billion, exceeding the consensus forecast of $6.602 billion.
The strong performance contributed to mixed U.S. stock markets, where the Dow Jones index gained around 300 points. Sherwin-Williams’ ability to exceed revenue and earnings benchmarks while upgrading its full-year outlook signals robust demand and effective cost management in the sector.
Market Movers
Several other major stocks recorded significant gains in Tuesday’s session, driven by positive earnings reports and strategic announcements:
| Company | Ticker | Exchange | Gain % | Closing Price | Catalyst |
|---|---|---|---|---|---|
| Prelude Therapeutics Inc | PRLD | NASDAQ | 24.7% | $4.85 | Market movement |
| Kiniksa Pharmaceuticals International, PLC | KNSA | NASDAQ | 22.9% | $78.09 | Beat Q2 results; raised FY26 sales guidance |
| OPKO Health Inc | OPK | NASDAQ | 23.8% | $1.54 | Beat Q2 sales results |
| Itron Inc | ITRI | NASDAQ | 20.4% | $102.04 | Beat Q2 adjusted EPS; raised FY26 guidance |
| Repligen Corp | RGEN | NASDAQ | 16.2% | $152.31 | Upbeat quarterly earnings |
| Iqvia Holdings Inc | IQV | NYSE | 14.0% | $243.10 | Beat quarterly results; raised FY26 guidance |
| Armstrong World Industries Inc | AWI | NYSE | 12.5% | $185.92 | Upbeat quarterly earnings |
| Air Global PLC | AIIR | NASDAQ | 11.5% | $6.58 | Market movement |
| ICON PLC | ICLR | NASDAQ | 10.2% | $185.97 | Multi-year collaboration with Anthropic on AI |
| TransUnion | TRU | NYSE | 8.7% | $84.00 | Quarterly results |
| Unilever PLC | UL | NYSE | 8.2% | $66.38 | H1 adjusted EPS increase; raised FY26 sales guidance |
| Simpson Manufacturing Co Inc | SSD | NYSE | 8.1% | $208.98 | Upbeat quarterly earnings |
| Charles River Lbrtrs ntrntl Inc | CRL | NYSE | 7.0% | $239.71 | Market movement |
| Coca-Cola Co | KO | NYSE | 6.6% | $89.63 | Beat Q2 results; raised FY26 EPS guidance |
| GSK plc | GSK | NYSE | 6.4% | $55.29 | Beat quarterly results; issued FY31 sales guidance |
What the Numbers Show
Sherwin-Williams demonstrated operational strength by exceeding both top-line and bottom-line expectations. The $0.18 per share beat on earnings and the $187 million surplus in sales against consensus highlights resilient consumer and professional demand. The decision to raise FY26 guidance suggests management expects this momentum to continue into the next fiscal year.
How might Sherwin-Williams' raised FY26 guidance influence the broader construction and home improvement sectors given the current housing market trends?
What specific cost management strategies did Sherwin-Williams implement to achieve these margins, and are they sustainable amid potential raw material price volatility?
Will the strong performance of industrial and consumer-facing stocks like Sherwin-Williams signal a broader shift in investor sentiment towards value and dividend-paying equities?
19
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
